Cambridge, United Kingdom

Sarah Joanne Bucknell

USPTO Granted Patents = 11 

 

 

Average Co-Inventor Count = 6.5

ph-index = 4

Forward Citations = 26(Granted Patents)


Location History:

  • Welwyn Garden City, GB (2017 - 2019)
  • Welwyn Garden, GB (2017 - 2019)
  • Cambridge, GB (2019 - 2021)

Company Filing History:


Years Active: 2017-2025

Loading Chart...
Loading Chart...
Loading Chart...
11 patents (USPTO):Explore Patents

Title: The Innovative Journey of Inventor Sarah Joanne Bucknell

Introduction

Sarah Joanne Bucknell, an accomplished inventor based in Cambridge, GB, has made significant contributions to the field of neuroscience through her innovative work on orexin receptor antagonists. With a total of 11 patents to her name, Bucknell is recognized for her dedication to advancing treatments for neurological and psychiatric disorders.

Latest Patents

Among her latest patents, Bucknell has developed compounds related to orexin 1 receptor antagonists. These novel compounds are defined by specific formulas and their potential applications in treating, preventing, and managing psychiatric and neurological disorders associated with orexin receptors. The disclosures include detailed information about the compounds and their salts, showcasing Bucknell's commitment to innovative scientific research.

Career Highlights

Throughout her career, Bucknell has played pivotal roles in various organizations, including Heptares Therapeutics Limited and Nxera Pharma UK Limited. Her work has focused on the development of medications aimed at enhancing mental health and neurological functions. Bucknell's contributions have not only advanced scientific knowledge but have also aimed to improve patient outcomes in a thriving area of medical research.

Collaborations

Sarah Joanne Bucknell has collaborated with notable professionals in her field, including John Andrew Christopher and Miles Stuart Congreve. These collaborations have fostered a productive environment for the exchange of ideas and innovation, enabling significant advancements in the understanding and treatment of neurological and psychiatric disorders.

Conclusion

In summary, Sarah Joanne Bucknell's innovative spirit and dedication to research have positioned her as a leading figure in neuropharmacology. Her patents and collaborations reflect a commitment to enhancing therapeutic options for patients suffering from complex disorders, solidifying her legacy in the field of invention and innovation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…